Analysis of haemodynamics and angiogenic response to ischaemia in the obese type 2 diabetic model Spontaneously Diabetic Torii Leprfa (SDT fatty) rats
- 16 January 2020
- journal article
- research article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 47 (4), 583-590
- https://doi.org/10.1111/1440-1681.13239
Abstract
Peripheral artery disease (PAD) is defined as peripheral blood flow impairment, especially in the legs, caused by atherosclerotic stenosis. The disease decreases quality of life because of intermittent claudication or necrosis of the leg. The hindlimb ischaemia model, in which ischaemia is induced by femoral artery ligation, is often utilized as a PAD model. In the hindlimb ischaemia model, nonmetabolic syndrome animals are mainly used. In this study, we investigated the usefulness of Spontaneously Diabetic Torii Lepr(fa) (SDT fatty) rats, a new model for obese type 2 diabetes, as a new PAD animal model. We found that hindlimb blood flow in SDT fatty rats was significantly lower than that in Sprague-Dawley (SD) rats under nonischaemic conditions. Furthermore, SDT fatty rats showed a significantly higher plasma nitrogen oxide level, shorter prothrombin time, and shorter activated partial thromboplastin time than SD rats. In addition, we found that the change in blood flow 7 days after induction of hindlimb ischaemia and the number of Von Willebrand factor-positive vessels in gastrocnemius muscles were significantly lower in SDT fatty rats than in SD rats. These results suggest that excess production of reactive oxygen species and coagulation activation could be involved in lower blood flow in non-ischaemic rats and that decreased angiogenesis could be involved in the poor recovery of blood flow in SDT fatty rats with hindlimb ischaemia. Taken together, our results suggest that SDT fatty rats might be useful as a new model for PAD with metabolic syndrome.Keywords
This publication has 26 references indexed in Scilit:
- Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: Roles of endothelial nitric oxide synthase and endothelial progenitor cellsJournal of Vascular Surgery, 2009
- Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)Journal of Vascular Surgery, 2007
- Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial diseaseEuropean Heart Journal, 2006
- The REduction of Atherothrombosis for Continued Health (REACH) Registry: An international, prospective, observational investigation in subjects at risk for atherothrombotic events-study designAmerican Heart Journal, 2006
- Impaired Revascularization in a Mouse Model of Type 2 Diabetes Is Associated With Dysregulation of a Complex Angiogenic-Regulatory NetworkArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Vascular function in patients with lower extremity peripheral arterial disease: a comparison of functions in upper and lower extremitiesAtherosclerosis, 2005
- A Novel Model of Obesity-Related Diabetes: Introgression of the Leprfa Allele of the Zucker Fatty Rat into Nonobese Spontaneously Diabetic Torii (SDT) RatsExperimental Animals, 2005
- Angiogenic Gene Therapy for Experimental Critical Limb IschemiaCirculation Research, 2002
- Nitric Oxide as a Potential Bridge Between the Metabolic and Vascular Hypotheses of Diabetic NeuropathyDiabetic Medicine, 1995
- Hypercoagulability and Reduced Fibrinolysis in Hyperlipidemia: Relationship to the Metabolic Cardiovascular SyndromeJournal of Cardiovascular Pharmacology, 1992